China Pharma Holdings (CPHI) Operating Leases (2019 - 2026)

China Pharma Holdings (CPHI) has reported Operating Leases for 8 consecutive years, with $148360.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases changed N/A year-over-year to $148360.0; the trailing twelve-month figure through Jun 2026 stood at $148360.0 (changed N/A YoY), and the FY2025 full-year result was $183176.0, up 365.82% from the prior year.
• Operating Leases climbed to $148360.0 in Q2 2026 per CPHI's latest filing, from $92294.0 in the prior quarter.
• Across five years, Operating Leases topped out at $198583.0 in Q3 2025 and bottomed at $20008.0 in Q1 2024.
• Historically, Operating Leases has averaged $94358.8 across 5 years, with a median of $87626.5 in 2022.
• The sharpest annual moves came in 2023 and 2025: Operating Leases slumped 81.08% in 2023, then surged 365.82% in 2025.
• Over 5 years, Operating Leases stood at $40445.0 in 2022, then retreated by 1.32% to $39910.0 in 2023, then dropped by 1.47% to $39323.0 in 2024, then soared by 365.82% to $183176.0 in 2025, then retreated by 19.01% to $148360.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $148360.0, $92294.0, and $183176.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.